Gastrointestinal (GI) stents are medical devices used to prevent the collapse of organs in the GI tract. They are majorly used to overcome benign and malignant formations caused by colorectal and esophageal cancers. Design of new stents such as Niti-S and Polyflex have been reduced to mitigate dysphagia associated with the above-mentioned cancers. This can be beneficial to individuals above the age of 60 that are susceptible to chronic diseases.
Prevention of Tumor Growth
The various types of GI stents are esophageal, pancreatic, colonic, biliary, and duodenal stents. The biliary stent segment had captured a major share of the GI stents market in 2016 on account of the high incidence of gallstone disease and bile duct cancer. The minimally invasive endoscopic procedure to place stents in benign bile duct cases is expected to be the primary factor contributing to revenue of this segment. Biodegradable stents are being increasingly used to treat any maladies in the biliary tract. These stents can dissolve without causing any adverse effects to the person.
The esophageal stent segment is projected to grow at a rapid rate due to continuous developments in self-expanding metal stents (SEMS) and self-expanding plastic stents (SEPS). The WallFlex stents by Boston Scientific are tough enough to resist the internal pressure of the muscles within the esophagus. It can even expand in its size to inhibit tumor growth.
Market Overview
The gastrointestinal (GI) stents market is estimated to be worth USD 472.5 million by 2025, according to a report by Grand View Research, Inc. The increasing number of GI cases including colorectal cancer, esophageal cancer, and biliary diseases are expected to be the major driver of the market. The rise in number of elderly populace susceptible to these diseases is expected to be another factor driving market demand over the forecast period (2014-2025).
In addition, government and private reimbursement schemes covering surgeries of these diseases are projected to drive market demand till 2025. The demand for endoscopic procedures is expected to augment market growth over the forecast period. Prominent market players include Taewoong Medical Co., Ltd., Boston Scientific Corporation, ELLA-CS, s.r.o., and Cook Group.
In-Depth Research Report On Gastrointestinal (GI) Stents Market:
https://www.grandviewresearch.com/industry-analysis/gastrointestinal-gi-stents-market
No comments:
Post a Comment